Personalized mRNA cancer vaccine shows promise in melanoma trial
Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients who had melanoma - a dangerous type of skin cancer.
ABC News
ABC News is your daily source for breaking national and world news, exclusive interviews and 24/7 live streaming coverage that will help you stay up to date on the events shaping our world. https://abcnews.go.com...